NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $326,237 | +0.5% | 3,203 | -0.4% | 0.07% | -1.4% |
| Q2 2023 | $324,506 | +16.7% | 3,216 | +6.4% | 0.07% | -11.4% |
| Q1 2023 | $278,097 | -11.2% | 3,023 | -12.5% | 0.08% | -16.0% |
| Q4 2022 | $313,225 | +5.5% | 3,453 | -11.7% | 0.09% | 0.0% |
| Q3 2022 | $297,000 | -8.0% | 3,910 | +2.4% | 0.09% | +5.6% |
| Q2 2022 | $323,000 | -33.1% | 3,820 | -30.6% | 0.09% | -28.8% |
| Q1 2022 | $483,000 | +2.1% | 5,507 | +1.8% | 0.12% | +7.8% |
| Q4 2021 | $473,000 | +287.7% | 5,412 | +262.7% | 0.12% | +132.0% |
| Q3 2021 | $122,000 | -60.6% | 1,492 | -56.2% | 0.05% | -43.8% |
| Q2 2021 | $310,000 | +33.6% | 3,403 | +25.6% | 0.09% | +14.1% |
| Q1 2021 | $232,000 | +38.1% | 2,709 | +52.3% | 0.08% | -40.0% |
| Q4 2020 | $168,000 | – | 1,779 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |